$CBIS Dr. Allen Herman, the CMO of the company, pointed out that the latest move would provide them with greater control over their supply chain and also improve their efficiencies. He also reassured the shareholders that they are planning to launch observational studies very soon, which would be targeted at critical ailments. Dr. Herman also claimed that a variety of cannabinoid combinations would be grown, by CBIS, for the purpose of formulating and testing.

http://mmjreporter.com/cannabis-science-inc-o...-2582.html